Biotechs Show Off Early-Stage Progress At AACR Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
Novel platforms presented at American Association for Cancer Research annual meeting generate workarounds for the blood-brain barrier (AngioChem), drug resistance (Avila) and tumor mutations (Micromet).